AI summary by TwinMind

Unapproved Trial for Discredited COVID Cure: Scandal In France

Sabine Hossenfelder

7m 58s

Background on Didier Raoult

  • French physician/microbiologist who claimed hydroxychloroquine cured COVID-19 in early pandemic
  • Director of tropical diseases research institute 2008-2022
  • Authored 2,300+ publications, highly cited microbiologist
  • Added his name to virtually every paper published at his institute
  • Specialized in tropical diseases/malaria treatment (hydroxychloroquine's normal use)

Initial Hydroxychloroquine Study (March 2020)

  • Published small trial claiming drug helps clear COVID from body
  • Study immediately criticized as highly problematic:
    • Treatment group much younger than control group on average
    • Six people who died removed from data
    • Dutch microbiologist Elizabeth Bick pointed out major flaws
  • Paper passed peer review within 24 hours despite issues
  • News spread globally with Donald Trump's enthusiastic support

Global Impact and Consequences

  • People worldwide rushed to pharmacies for hydroxychloroquine
  • Man in Arizona died from poisoning with similar fish tank cleaning substance
  • Raoult gained dedicated anti-vaxxer following via Twitter promotion
  • Follow-up trials conducted but results not reproducible
  • Larger trials found no significant impact on COVID prevention/treatment
  • Drug has many side effects
  • National health agencies recommended against COVID use

Legal Battles with Critics

  • Raoult attacked critics of his research, particularly Elizabeth Bick
  • Speculated she was paid by pharmaceutical industry to discredit competitor to antiviral remdesivir
  • Sued Bick for alleged harassment and blackmail
  • April 2023: French court dismissed charges against Bick after 3 years
  • Raoult still claimed on Twitter last week that she harasses him

New Large-Scale Trial Announcement

  • 2023: Raoult announced huge new trial with 30,000+ participants
  • Claimed drug reduces COVID mortality, validating earlier conclusions
  • Trial ran March 2020 through end of 2021
  • Continued long after French government withdrew permission for COVID treatment
  • Had no ethics approval, putting patients at unnecessary risk
  • Paper published October 2023 in Elsevier journal

Academic Response and Investigations

  • Open letter published in French newspaper Le Monde
  • Signed by 14 learned societies calling for investigation
  • Attention drawn to Raoult's other studies lacking ethics approval

Additional Legal Case

  • Raoult sued Julio Limosa, mathematics professor
  • Limosa compiled list of Raoult's paper shortcomings on Twitter
  • Raoult argued this constituted defamation
  • Court hearing disrupted by anti-vaxxers shouting insults at Limosa
  • Raoult discussed supposed achievements but court dismissed charges

Publisher Actions and Retractions

  • December 2022: Publisher flagged 49 studies from Raoult's institute for possible ethics violations
  • American Society for Microbiology retracted 7 papers
  • Many studies conducted on vulnerable populations (homeless, refugees)
  • Scientific Reports also involved in retractions

TwinMind

Get summaries like this for your own meetings

TwinMind takes notes in the background during meetings, lectures, and calls, then writes the summary for you.

Free plan to get started

No bot joins your calls

Phone, desktop & Chrome apps

Your next meeting, summarized like this

TwinMind listens in the background and turns meetings, lectures, and calls into searchable notes you can chat with. Start free.

Available on phone, desktop & Chrome

Your next meeting, summarized like this

TwinMind listens in the background and turns meetings, lectures, and calls into searchable notes you can chat with. Start free.

Available on phone, desktop & Chrome

Your next meeting, summarized like this

TwinMind listens in the background and turns meetings, lectures, and calls into searchable notes you can chat with. Start free.

Available on phone, desktop & Chrome